# US 2021/0330715 A1 · Anti-biofilm agents and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330715 A1
- Document ID: US20210330715A1
- Status: Published application
- Kind: A1
- Application number: 17/237,479
- Filed: 2021-04-22
- Published: 2021-10-28
- Earliest claimed: 2020-04-23
- Applicants: AmebaGone, LLC
- Inventors: Marcin Filutowicz; Dhanansayan Shanmuganayagam; Nathan James Chesmore
- Web page: https://patentgrep.com/patent/US20210330715A1

## CPC

- A61K 35/68: Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
- A01N 63/00: Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates (containing compounds of determined constitution A01N27/00 - A01N59/00; unicellular algae A01N65/03)
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61P 31/04: Antibacterial agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to anti-biofilm components of amoebae to target biofilms.

## Claims

### Claim 1

A method of treating or preventing a biofilm accumulation, comprising:
contacting said biofilm with a composition comprising one or more amoebae components.

### Claim 2 (depends on 1)

The method of claim 1, wherein said amoebae components are biological molecules secreted by said amoebae.

### Claim 3 (depends on 2)

The method of claim 2, wherein said biological molecules are selected from the group consisting of proteins, small molecules, and metabolites.

### Claim 4 (depends on 1)

The method of claim 1, wherein said biofilm is produced by a microbial organism selected from the group consisting of bacteria, protozoa, amoeba, and fungi.

### Claim 5 (depends on 1)

The method of claim 1, wherein said microbial organisms are pathogenic.

### Claim 6 (depends on 1)

The method of claim 1, wherein said biofilm is in or on a surface.

### Claim 7 (depends on 1)

The method of claim 1, wherein said biofilm is in or on a subject.

### Claim 8 (depends on 1)

The method of claim 1, wherein said biofilm is in a wound.

### Claim 9 (depends on 7)

The method of claim 7, wherein said biofilm is on a mucus membrane of said subject.

### Claim 10 (depends on 7)

The method of claim 7, wherein said biofilm is in an organ or tissue of said subject.

### Claim 11 (depends on 1)

The method of claim 1, wherein said biofilm is in or on a plant.

### Claim 12 (depends on 1)

The method of claim 1, wherein said composition comprises two or more amoebae components.

### Claim 13 (depends on 1)

The method of claim 1, wherein said amoebae are selected from the group consisting of Dictyostelium discoideum (WS-28 and WS-647 and X3); D. minutum (Purdue 8a); D. mucoroides (Turkey 27, WS-20, WS-142, WS-255); D. mucoroides complex (WS-309); D. purpureum (WS-321.5 and WS-321.7); D. rosarium (TGW-11); D. sphaerocephalum (FR-14); Polysphondylium pallidum (Salvador); P. violaceum (WS-371a) and unknown isolate (Tu-4b).

### Claim 14 (depends on 1)

The method of claim 1, wherein said composition further comprises a non-amoebae anti-microbial agent.

### Claim 15 (depends on 1)

The method of claim 1, wherein said composition is a pharmaceutical agent.

### Claim 16 (depends on 6)

The method of claim 6, wherein said surface is a shower drain, water pipe, sewage pipe, food preparation surface, gas or oil pipeline, medical device, contact lens, or ship hull.

### Claim 17 (depends on 1)

The method of claim 1, wherein the biofilm is located on the surface at a facility selected from the group consisting of hospitals, laboratories, water treatment facilities, sewage treatment facilities, dental and/or medical offices, water distribution facilities, nuclear power plant, pulp or paper mill, air and/or water handling facility, pharmaceutical manufacturing facility, and dairy manufacturing facility.

### Claim 18

A method of treating a subject infected with a biofilm, comprising: contacting a subject infected with a biofilm with a pharmaceutical composition comprising one or more amoebae components.

### Claim 19 (depends on 18)

The method of claim 18, wherein said subject is a human.

### Claim 20

A pharmaceutical composition, comprising:
a) one or more amoebae components; and
b) a pharmaceutically acceptable carrier.
